The pharmacy has 30 generics and 40 OTC products in the pipeline for FY 2019
Medlife.com will launch its private label generic drugs. A first for any online pharmacy, Medlife’s launch of generic drugs is in keeping with the Government of India’s recent efforts to encourage the use of affordable generic drugs, instead of expensive brand-named alternatives.
Medlife has plans to launch about 30 generic drugs and 40 OTC products by the next financial year. The Bengaluru – based health technology company expects a revenue of Rs 100 crore from the private label offering.
With its launch of private label generics, Medlife aims to make quality medicines affordable for Indians. For instance, the company will soon launch reasonably-priced, DMF-grade Paracetamol 650 mg that promises up to 92 per cent drug release within just five minutes, to provide instant relief from fever and pain. The drugs will be manufactured in a WHO-GMP, PICS, HACCP, ISO 22000:2005 certified and approved plant.
Speaking about the company’s long-term plans, Tushar Kumar, CEO, Medlife said, “Being on the frontlines of the healthcare sector, pharmacy has the potential to be a real game-changer. Our vision is to develop a comprehensive and ethical healthcare ecosystem that makes healthcare affordable, accessible and responsive to the needs of all Indians. Promotion of generic drugs is a significant step in bringing down healthcare expenses and making medicines easily available to the common man. We need to spread awareness about the promise of pure generics among doctors and patients alike. In line with the Government of India’s push for generic drugs, we believe in its far-reaching benefits, especially in public health. Bringing together the best of technology and robust healthcare delivery system, Medlife is committed to bridging the yawning gaps in India’s healthcare system.”